The Department of Justice (DOJ) has raised concerns that a lawsuit challenging federal marijuana prohibition could potentially undermine ongoing efforts to reschedule cannabis. In a recent court brief, the DOJ suggested that if marijuana companies win their case, it could limit the government’s ability to regulate cannabis as a Schedule III drug.

This development comes as various states continue to grapple with cannabis-related issues. Hawaii is seeking proposals to analyze cannabis demand, while Minnesota’s Psychedelic Medicine Task Force is recommending the decriminalization of magic mushrooms. In Texas, officials are calling for an expansion of the state’s limited medical cannabis program.

Meanwhile, Willie Nelson is urging Dallas voters to support a local marijuana decriminalization measure, highlighting the ongoing push for cannabis reform at both state and local levels.

These developments underscore the complex and evolving landscape of cannabis policy in the United States.